LURIE CANCER CENTER M

ultidisciplinary Head & Neck Symposium

Novem

ber 10-11, 2018

Northw

estern Mem

orial Hospital Feinberg Pavilion 3rd Floor Conference Center 251 E. Huron St., Chicago

CON

FERENCE CH

AIR

Sandeep Samant, M

DChief, H

ead & N

eck Surgery N

orthwestern M

edicine

VISIT OU

R WEBSITE:

cancer.northwestern.edu/headneck

QU

ESTION

S:

erin.donoghue@northw

estern.edu

Agenda & Program Inform

ation

The Lurie Cancer Center Multidisciplinary Head & Neck Symposium is a one and one-half day interactive program on the diagnosis, treatment and rehabilitation of head and neck cancer patients. The symposium brings together medical oncologists, radiation oncologists, otolaryngologists, head and neck surgeons, dentists, nurses and allied health professionals to discuss and debate the latest advances in multidisciplinary therapies, clinical research and supportive care methodology. The agenda features internationally-recognized experts who will engage attendees in dialogue to improve multi-specialty collaboration in the treatment and care of head and neck cancer patients.

cancer.northwestern.edu/headneck

676 N St. Clair, Suite 1200Chicago, IL 60611

Register by August 31 for early bird discount; prices increase September 1.

LURIE CANCER CENTER Multidisciplinary Head & Neck SymposiumNovember 10-11, 2018

LEARNING OBJECTIVES 1. Apply a multidisciplinary approach to the treatment of head and neck cancer.2. Assess state-of-the art therapeutic options for the treatment of head and neck cancer including:

i. Minimally invasive surgical treatment including robotic surgery, image-guided skull base surgery, and sentinel lymph node mapping.

ii. Novel radiation delivery methods including proton beam therapy and image-guided radiation therapy (IGRT). iii. Incorporation of immunotherapy for treatment of advanced head and neck cancer.

3. Discuss future directions to the treatment of head and neck cancer based on the latest basic science and clinical developments including:

i. The diagnosis and treatment of human papillomavirus (HPV) positive oropharyngeal. ii. The latest developments in the molecular biology of head and neck cancer and its impact on management.iii. The role of biomarkers in the contemporary management of head and neck cancer. iv. Strategies for recognition and treatment of adverse effects of immunotherapy.

4. Discuss new staging guidelines (8th edition AJCC) for head and neck cancer.5. Apply current treatment guidelines to patients with head and neck cancer. 6. Integrate quality measures for the care of head and neck cancer into their own clinical practice.

7:45 a.m. - Opening RemarksSandeep Samant, MD

8:00 a.m. - Oropharynx Cancer IModerator: Robert Haddad, MDRisk Stratification in Oropharynx Cancer: Sue Yom, MD, PhD Radiation Strategies for De-Intensification: Paul Harari, MDChemotherapeutic Considerations: A. Dimitrios Colevas, MDCase Discussion: A. Dimitrios Colevas, MD; Paul Harari, MD; Randal Weber, MD; Sue Yom, MD, PhD

9:30 a.m. - Larynx CancerModerator: Gregory Wolf, MDOrgan Preservation Surgery for Larynx Cancer: Bruce Haughey, MDNonsurgical Organ Preservation: Robert Haddad, MDCase Discussion: Robert Haddad, MD; Bruce Haughey, MD; Bharat Mittal, MD

10:30 a.m. - Break10:45 a.m. - Oropharynx Cancer II

Moderator: Sandeep Samant, MDRisk Stratification after Surgery for Oropharynx Cancer, 8th Edition Staging: Bruce Haughey, MDInnovations in Surgical Technique and Technology: Chris Holsinger, MDAdjuvant Therapy in Oropharynx Cancer: Harry Quon, MDCase Discussion: A. Dimitrios Colevas, MD; Bruce Haughey, MD; Chris Holsinger, MD; Harry Quon, MD

12:15 p.m. - Lunch1:15 p.m. - Oral Cavity

Moderator: Kerstin Stenson, MD Sentinel Node Biopsy for Early Oral Cancer: Sandeep Samant, MDReconstruction for Advanced Oral Cancer: Urjeet Patel, MDProsthetic Rehabilitation for Mandibular Defects: Mark Hutten, DDSAdjuvant Therapy for Oral Cancers: Timothy Kruser, MDCase Discussion: Mark Hutten, DDS; Timothy Kruser, MD; Urjeet Patel, MD; Sandeep Samant, MD

2:15 p.m. - ThyroidModerator: Ashok Shaha, MDMolecular Diagnosis of Thyroid Nodules: Whitney Liddy, MDRisk Stratification After Surgery and Indications of Radioactive Iodine Therapy: Peter Kopp, MDDrug Therapy for Thyroid Cancer: Maria Matsangou, MDIndications for EBRT in Thyroid Cancer: Sue Yom, MD, PhDCase Discussion: Chris Holsinger, MD; Peter Kopp, MD; Whitney Liddy, MD; Maria Matsangou, MD; Sue Yom, MD, PhD

3:45 p.m. - Break4:00 p.m. - Cutaneous Malignancies in Head and Neck Cancer

Moderator: Randal Weber, MDManagement of Lymphatic Metastasis in Head Neck Melanoma: Jeffrey Wayne, MDWhat’s New in the World of Cutaneous Head and Neck Malignancies: Sunandana Chandra, MD, MSHow Best to Utilize Mohs Surgery in Cutaneous Head Neck Cancer: Simon Yoo, MDNMSC at the Skull Base: Radiation Therapy Versus Combined Therapy: Sue Yom, MD, PhDCase Discussion: Sunandana Chandra, MD, MS; Jeffrey Sosman, MD; Jeffrey Wayne, MD; Sue Yom, MD, PhD; Simon Yoo, MD

5:45 p.m. - Adjourn

8:00 a.m. - Immunotherapy in Head and Neck CancerModerator: Jeffrey Sosman, MDAdvances in Immunotherapy for Cancer: Jeffrey Sosman, MDImmunotherapy for Recurrent/Metastatic Head and Neck Cancer: Tanguy Seiwert, MDCombining Immunotherapy with Radiotherapy: Zachary Morris, MD, PhDManagement of Adverse Effects with Immunotherapy: Douglas Johnson, MDQuestion & Answer

9:30 a.m. - Unknown Primary CancerModerator: Urjeet Patel, MDModern Approaches for Identification of Unknown Primary: Chris Holsinger, MDAvoiding Pitfalls in Pathologic Diagnosis: Borislav Alexiev, MDImaging for Unknown Primary Cancer: Achilles Karagianis, DOWe identified the Primary, Now What? Harry Quon, MDCase Discussion: Borislav Alexiev, MD; Chris Holsinger, MD; Achilles Karagianis, DO; Harry Quon, MD

10:45 a.m. - Boxed Lunch Break 11:00 a.m. - Head and Neck Oncology: Where Are We Now and Where Are We Going? Coverage from the 2018 ASCO Annual Meeting

Mark Agulnik, MD; A. Dimitrios Colevas, MD; Tanguy Seiwert, MD; Matthew Witek, MD

11:45 a.m. - Tumor Board: Paranasal Sinus, Nasopharynx, SalivaryModerator: Sandeep Samant, MDMichelle Gentile, MD, PhD; Harry Quon, MD; Kerstin Stenson, MD; Victoria Villaflor, MD; Randal Weber, MD

1:15 p.m. - Adjourn

Mark Agulnik, MDLurie Cancer Center

Borislav Alexiev, MDNorthwestern Medicine

Sunandana Chandra, MD, MSLurie Cancer Center

A. Dimitrios Colevas, MDStanford Cancer Center

Michelle Gentile, MDLurie Cancer Center

Robert Haddad, MDDana-Farber Cancer Institute

Paul Harari, MDUniversity of Wisconsin Carbone Cancer Center

Bruce Haughey, MDFlorida Hospital Medical Group

Chris Holsinger, MDStanford Cancer Center

Mark Hutten, DDSNorthwestern Medicine

Douglas Johnson, MDVanderbilt-Ingram Cancer Center

Achilles Karagianis, DONorthwestern Medicine

Peter Kopp, MDLausanne University Medical School

Timothy Kruser, MDLurie Cancer Center

Whitney Liddy, MDNorthwestern Medicine

Maria Matsangou, MBChBLurie Cancer Center

Bharat Mittal, MDLurie Cancer Center

Zachary Morris MD, PhDUniversity of Wisconsin Carbone Cancer Center

Urjeet Patel, MDNorthwestern Medicine

Harry Quon, MDSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sandeep Samant, MDNorthwestern Medicine

Tanguy Seiwert, MDThe University of Chicago Medicine

Ashok Shaha, MDMemorial Sloan Kettering Cancer Center

Jeffrey Sosman, MDLurie Cancer Center

Kerstin Stenson, MDRush University Medical Center

Victoria Villaflor, MDLurie Cancer Center

Jeffrey Wayne, MDLurie Cancer Center

Randal Weber, MDUniversity of Texas MD Anderson Cancer Center

Matthew Witek, MDUniversity of Wisconsin Carbone Cancer Center

Gregory Wolf, MDUniversity of Michigan Rogel Cancer Center

Sue Yom, MD, PhDUCSF Helen Diller Family Comprehensive Cancer Center

Simon Yoo, MDLurie Cancer Center

FACULTY

cancer.northwestern.edu/headneckTARGET AUDIENCEThe target audience for this activity includes medical oncologists, radiation oncologists, surgical oncologists, fellows in training, oncology nurses, oral surgeons, dentists, speech pathologists and allied health professionals treating or interested in treating those with head and neck cancer.

ACCREDITATION STATEMENTThe Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATIONThe Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITSThe American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

SATURDAY, NOVEMBER 10 SUNDAY, NOVEMBER 11

This symposium is made possible, in part, by the generous endowed gift of Harry Staffileno, Jr., DDS, MS to support oncology-related oral health at Northwestern Medicine.